0001209191-17-027983.txt : 20170424
0001209191-17-027983.hdr.sgml : 20170424
20170424163416
ACCESSION NUMBER: 0001209191-17-027983
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170424
FILED AS OF DATE: 20170424
DATE AS OF CHANGE: 20170424
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 17778587
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC
CENTRAL INDEX KEY: 0001581774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 17778588
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: X1
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene Switzerland LLC
CENTRAL INDEX KEY: 0001661486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 17778589
BUSINESS ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
BUSINESS PHONE: 4412964803
MAIL ADDRESS:
STREET 1: AON HOUSE
STREET 2: 30 WOODBOURNE AVENUE
CITY: PEMBROKE
STATE: D0
ZIP: HM 08
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celgene European Investment Co LLC
CENTRAL INDEX KEY: 0001577650
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 17778590
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: 908-673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-24
0
0001439222
AGIOS PHARMACEUTICALS INC
AGIO
0001577650
Celgene European Investment Co LLC
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0001661486
Celgene Switzerland LLC
AON HOUSE
30 WOODBOURNE AVENUE
PEMBROKE
D0
HM 08
BERMUDA
0
0
1
0
0001581774
Celgene Alpine Investment Co., LLC
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
0000816284
CELGENE CORP /DE/
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
0
1
0
Common Stock
2017-04-24
4
P
0
624575
49.50
A
1856353
I
See footnote
Common Stock
4010926
D
Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC ("Celgene Switzerland"), 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC ("Celgene Alpine"), each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene and Celgene European Investment Company LLC, a wholly owned subsidiary of Celgene ("CEICO"), disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. The remaining 523,445 shares are owned directly by Celgene. CEICO, Celgene Switzerland and Celgene Alpine disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
These shares are owned directly by CEICO, and Celgene has the power to vote, acquire, hold and dispose of all shares. Celgene, Celgene Switzerland and Celgene Alpine disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
/s/Kevin Mello, Manager, Celgene European Investment Company LLC
2017-04-24
/s/ Kevin Mello, Manager, Celgene Switzerland LLC
2017-04-24
/s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC
2017-04-24
/s/ Peter N. Kellogg, Executive Vice President & Chief Financial Officer, Celgene Corporation
2017-04-24